The course content and learning outcomes are guided by the pharmacy regulator, the General Pharmaceutical Council (GPhC). The course is appropriately taught and assessed through a blend of learning styles including eight face-to-face sessions and one remote instructional delivery session, practice-based activities and a large element of distance learning. Our face-to-face sessions are delivered by practitioners who are experts in their field as well as academic staff who will deliver specialist training.
All study days must be attended and confirmation that you are able to attend is required prior to course starting. You will be required to undertake the equivalent of 26 days learning in addition to a minimum of 90 hours patient contact overseen by your designated prescribing practitioner in practice.
The course will broadly cover the following main themes:
The course is at master’s level 7 and you will be assessed by compiling a portfolio of evidence and an OSCE to test your clinical skill competencies. Passing of all required assessments will enable you to apply for annotation as a prescriber with the GPhC.